Pharind Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.86 Cr
- Revenue Growth 13.79%
- Profit Growth 4.75%
- Ebitda 37.63%
- Net Worth 43.39%
- Total Assets 21.64%
About Pharind Pharmaceuticals
Pharind Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2015 and has a history of Ten years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.86 Cr.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900MH2015PTC261485
-
Company No.
261485
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jan 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Pharind Pharmaceuticals Private Limited offer?
Pharind Pharmaceuticals Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Medical Consultants & Clinics, Skin Treatment Solution.
Who are the key members and board of directors at Pharind Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirbhaynarayan Singh
|
Director | 19-Jul-2017 | Current |
|
Prayagdatt Mishra
|
Director | 30-Jan-2015 | Current |
Financial Performance of Pharind Pharmaceuticals.
Pharind Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.79% increase. The company also saw a slight improvement in profitability, with a 4.75% increase in profit. The company's net worth Soared by an impressive increase of 43.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharind Pharmaceuticals?
Unlock access to Pharind Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hvax Technologies LimitedNirbhaynarayan Singh and Prayagdatt Mishra are mutual person
-
Pnx Enterprises LlpNirbhaynarayan Singh and Prayagdatt Mishra are mutual person
Charges (Loans)
₹28.60 M
₹0
Charges Breakdown by Lending Institutions
- Tjsb Sahakari Bank Limited : 2.86 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Apr 2022 | Tjsb Sahakari Bank Limited | ₹3.30 M | Open |
| 01 Feb 2022 | Tjsb Sahakari Bank Limited | ₹3.30 M | Open |
| 19 Jan 2019 | Tjsb Sahakari Bank Limited | ₹1.10 Cr | Open |
| 17 Jan 2019 | Tjsb Sahakari Bank Limited | ₹1.10 Cr | Open |
How Many Employees Work at Pharind Pharmaceuticals?
Unlock and access historical data on people associated with Pharind Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharind Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharind Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
